2024 ICD-10-CM Diagnosis Code Q81.8

Other epidermolysis bullosa

ICD-10-CM Code:
Q81.8
ICD-10 Code for:
Other epidermolysis bullosa
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Congenital malformations, deformations and chromosomal abnormalities
    (Q00-Q99)
    • Other congenital malformations
      (Q80-Q89)
      • Epidermolysis bullosa
        (Q81)

Q81.8 is a billable diagnosis code used to specify a medical diagnosis of other epidermolysis bullosa. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abnormal granulation tissue
  • Aplasia cutis congenita in association with epidermolysis bullosa
  • Autosomal dominant epidermolysis bullosa simplex
  • Cicatricial junctional epidermolysis bullosa
  • Congenital junctional epidermolysis bullosa
  • Congenital junctional epidermolysis bullosa
  • Congenital junctional epidermolysis bullosa-pyloric atresia syndrome
  • Epidermolysis bullosa pruriginosa
  • Gastric atresia
  • Generalized dystrophic epidermolysis bullosa
  • Generalized junctional epidermolysis bullosa
  • Generalized junctional epidermolysis bullosa
  • Granulation of skin
  • Inverse junctional epidermolysis bullosa
  • Junctional epidermolysis bullosa
  • Junctional epidermolysis bullosa mitis
  • Junctional epidermolysis bullosa non-Herlitz type
  • Laryngo-onycho-cutaneous syndrome
  • Late-onset junctional epidermolysis bullosa
  • Late-onset localized junctional epidermolysis bullosa, intellectual disability syndrome
  • Localized junctional epidermolysis bullosa
  • Localized junctional epidermolysis bullosa
  • Localized non-Herlitz junctional epidermolysis bullosa
  • Progressive junctional epidermolysis bullosa
  • Pyloric atresia
  • Weber-Cockayne syndrome

Clinical Classification

Clinical Information

  • Epidermolysis Bullosa

    group of genetically determined disorders characterized by the blistering of skin and mucosae. there are four major forms: acquired, simple, junctional, and dystrophic. each of the latter three has several varieties.
  • Epidermolysis Bullosa Acquisita

    form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. direct immunofluorescence shows immunoglobulin g deposited at the dermo-epidermal junction.
  • Epidermolysis Bullosa Dystrophica

    form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. it is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. all forms of dystrophic epidermolysis bullosa result from mutations in collagen type vii, a major component fibrils of basement membrane and epidermis.
  • Epidermolysis Bullosa Simplex

    a form of epidermolysis bullosa characterized by serous bullae that heal without scarring. mutations in the genes that encode keratin-5 and keratin-14 have been associated with several subtypes of epidermolysis bullosa simplex.
  • Epidermolysis Bullosa, Junctional

    form of epidermolysis bullosa having onset at birth or during the neonatal period and transmitted through autosomal recessive inheritance. it is characterized by generalized blister formation, extensive denudation, and separation and cleavage of the basal cell plasma membranes from the basement membrane.
  • Junctional Epidermolysis Bullosa

    epidermolysis bullosa characterized by separation of the skin through the lamina lucida resulting in blister formation. it includes lethal and non-lethal variants.
  • LAMC2 wt Allele|B2T|BM600|CSF|EBR2|EBR2A|LAMB2T|LAMNB2|Lam5, Gamma-2 Subunit Gene|Laminin 5, Gamma-2 Subunit Gene|Laminin, Gamma 2 (Nicein (100kD), Kalinin (105kD), BM600 (100kD), Herlitz Junctional Epidermolysis Bullosa)) Gene|Laminin, Gamma 2 wt Allele|Laminin, Gamma-2 Gene|Laminin, Nicein, Beta-2 Gene

    human lamc2 wild-type allele is located within 1q25-q31 and is approximately 59 kb in length. this allele, which encodes laminin subunit gamma-2 protein, is involved in both the development of the epidermis and extracellular matrix organization. mutation of the gene is associated with herlitz junctional epidermolysis bullosa.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Present on Admission (POA)

Q81.8 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert Q81.8 to ICD-9-CM

  • ICD-9-CM Code: 757.39 - Skin anomaly NEC
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Skin Conditions

What does your skin do?

Your skin is your body's largest organ. It covers the entire outside of your body. There are many ways that your skin protects your body and helps keep you healthy. For example, it:

  • Holds body fluids in, which helps prevent you from getting dehydrated
  • Keeps out harmful germs, which helps prevent infections
  • Helps you feel things like heat, cold, and pain
  • Helps control your body temperature
  • Makes vitamin D when the sun shines on it
  • Shields your body against heat and light

What problems and conditions can affect your skin?

There are many different problems and conditions which can affect your skin. Some of them can cause uncomfortable symptoms, such as itching, burning, redness, and rashes. They might also affect your appearance. Some of the more common skin conditions include:

  • Acne, which causes pimples when hair follicles under your skin get clogged up
  • Burns
  • Cuts and scrapes
  • Dandruff, flaking of the skin on your scalp (the top of your head)
  • Eczema (atopic dermatitis), which causes inflammation, redness, and irritation of the skin
  • Hives, which are red and sometimes itchy bumps on your skin
  • Insect bites
  • Psoriasis, which causes itchy, scaly red patches
  • Skin cancer
  • Skin infections

How can I keep my skin healthy?

Since your skin protects your body in many ways, it's important to try to keep your skin healthy. For example, you can:

  • Wear the right protective equipment, like gloves, long sleeves, knee and elbow pads, or helmets to protect against cuts, bumps and scrapes.
  • If you do get a cut or scrape, clean it right away with soap and warm water. Put on a bandage to protect it while it heals.
  • When you are spending time outdoors, wear long sleeves and pants and use insect repellant to prevent insect bites.
  • Prevent sunburn by covering up and using sunscreen when outdoors.
  • Wash your hands often with soap and water.
  • When you take a shower or bath, use warm (not hot) water. Use mild cleansers and wash gently (don't scrub).
  • Use moisturizers, like lotions, creams, or ointments, to prevent dry skin.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases


[Learn More in MedlinePlus]

Junctional epidermolysis bullosa

Junctional epidermolysis bullosa (JEB) is a major form of epidermolysis bullosa, a group of genetic conditions that cause the skin to be very fragile and to blister easily. Blisters and areas of skin loss (erosions) form in response to minor injury or friction, such as rubbing or scratching. Researchers classify junctional epidermolysis bullosa into two main types: JEB generalized severe (formerly known as Herlitz JEB) and JEB generalized intermediate (formerly known as non-Herlitz JEB). Although the types differ in severity, their features overlap significantly, and they can be caused by mutations in the same genes.

JEB generalized severe is the more serious form of the condition. From birth or early infancy, affected individuals have blistering over large regions of the body. Blistering also affects the mucous membranes, such as the moist lining of the mouth and digestive tract, which can make it difficult to eat and digest food. As a result, many affected children are undernourished and grow slowly. The extensive blistering leads to scarring and the formation of red, bumpy patches called granulation tissue. Granulation tissue bleeds easily and profusely, making affected infants susceptible to serious infections and loss of necessary proteins, minerals, and fluids. Additionally, a buildup of granulation tissue in the airway can lead to a weak, hoarse cry and difficulty breathing.

Other complications of JEB generalized severe can include fusion of the fingers and toes, abnormalities of the fingernails and toenails, joint deformities (contractures) that limit movement, hair loss (alopecia), and thinning of the protective outer layer (enamel) of the teeth. Because the signs and symptoms of JEB generalized severe are so serious, infants with this condition usually do not survive beyond the first year of life.

The milder form of junctional epidermolysis bullosa is called JEB generalized intermediate. The blistering associated with JEB generalized intermediate may be limited to the hands, feet, knees, and elbows, and it often improves after the newborn period. Other characteristic features of this form of the condition include hair loss, abnormal fingernails and toenails, and irregular tooth enamel. Most affected individuals do not have extensive scarring or granulation tissue formation, so breathing difficulties and other severe complications are rare. JEB generalized intermediate is typically associated with a normal lifespan.


[Learn More in MedlinePlus]

Epidermolysis Bullosa

Epidermolysis bullosa is a group of rare diseases that cause fragile skin that leads to blistering and tearing.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.